Related Content
January 31, 2013 โ Biosensors International has announced CE mark approval for its polymer-free drug-coated stent (DCS) ...
January 31, 2013
January 7, 2013 โ Biosensors International has announced enrollment of the first patient in LEADERS FREE, a clinical ...
January 07, 2013
November 2, 2012 โ Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are ...
November 02, 2012June 21, 2012 โ Plans for a new study involving BioFreedom, the polymer-free drug-coated stent (DCS) from Biosensors ...
June 21, 2012
May 22, 2012 โ New long-term data from the DIVERGE study presented at EuroPCR 2012 showed that the use of the Axxess ...
May 22, 2012
March 27, 2012 โ Biodegradable polymer drug-eluting stents (DES) provide better long-term safety and efficacy than ...
March 27, 2012
November 11, 2011 โ Biosensors International Group announced two-year results from the BioFreedom first-in-human trial ...
November 11, 2011
November 8, 2011 โ Biosensors International Group Ltd. announced final results of the AXXESS PLUS trial, which ...
November 08, 2011October 7, 2011 โ Biosensors has announced completion of its acquisition of JW Medical Systems Ltd. (JWMS), one of the ...
October 07, 2011
Feature | Kamran Zamanian, Ph.D., and Jamie Stillborn, iData Research Inc.
For decades, stents have been used in coronary and peripheral procedures in Europe and the United States to prevent or ...
September 21, 2011ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now